Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Molecular assay for screening and quantifying DNA in biological evidence: the modified Q-TAT assay.

Wilson J, Fuller V, Benson G, Juroske D, Duvall E, Fu J, Pritchard J, Allen RW.

J Forensic Sci. 2010 Jul;55(4):1050-7. doi: 10.1111/j.1556-4029.2010.01371.x. Epub 2010 Apr 8.

PMID:
20384933
2.

Inhibition of mammalian target of rapamycin reverses alveolar epithelial neoplasia induced by oncogenic K-ras.

Wislez M, Spencer ML, Izzo JG, Juroske DM, Balhara K, Cody DD, Price RE, Hittelman WN, Wistuba II, Kurie JM.

Cancer Res. 2005 Apr 15;65(8):3226-35.

3.

Murine lung tumor measurement using respiratory-gated micro-computed tomography.

Cody DD, Nelson CL, Bradley WM, Wislez M, Juroske D, Price RE, Zhou X, Bekele BN, Kurie JM.

Invest Radiol. 2005 May;40(5):263-9.

PMID:
15829823
4.

Aberrant epidermal growth factor receptor signaling and enhanced sensitivity to EGFR inhibitors in lung cancer.

Amann J, Kalyankrishna S, Massion PP, Ohm JE, Girard L, Shigematsu H, Peyton M, Juroske D, Huang Y, Stuart Salmon J, Kim YH, Pollack JR, Yanagisawa K, Gazdar A, Minna JD, Kurie JM, Carbone DP.

Cancer Res. 2005 Jan 1;65(1):226-35.

5.

c-Jun N-terminal kinase contributes to aberrant retinoid signaling in lung cancer cells by phosphorylating and inducing proteasomal degradation of retinoic acid receptor alpha.

Srinivas H, Juroske DM, Kalyankrishna S, Cody DD, Price RE, Xu XC, Narayanan R, Weigel NL, Kurie JM.

Mol Cell Biol. 2005 Feb;25(3):1054-69.

Supplemental Content

Loading ...
Support Center